Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024).

Mov Disord

Department of Neurology and Neurological Surgery (Neurology), Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Published: September 2002

We report on a patient with cranio-cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.10209DOI Listing

Publication Analysis

Top Keywords

botulinum toxin
16
secondary resistance
8
toxin
5
secondary nonresponsiveness
4
nonresponsiveness bulk
4
botulinum
4
bulk botulinum
4
toxin bcb2024
4
bcb2024 report
4
report patient
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!